Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion

American Journal of Transplantation

Volumn 7, Issue 4, 2007, Pages 949-954

  Kayler, L K ^a   Lakkis, F G ^a   Morgan, C ^a   Basu, A ^a   Blisard, D ^a   Tan, H P ^a   McCauley, J ^a   Wu, C ^a   Shapiro, R ^a   Randhawa, P S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Acute rejection; B cells; CD20

Indexed keywords

ALEMTUZUMAB; CD20 ANTIBODY; CD20 ANTIGEN; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 33947602356     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01737.x     Document Type: Article

References (24)

1. Racusen LC, Solez K, Olsen S. Pathology of kidney transplantation. In: Racusen LC, Solez K, Burdick JF, eds. Kidney Transplant Rejection-Diagnosis and Treatment, 3rd Ed. New York, Marcell Dekker, Inc. 1998: 383.
2. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
3. Colvin RB. The renal allograft biopsy. Kidney Int 1996; 50: 1069-1082.
4. David-Neto E, Ribeiro DS, Ianhez LE et al. Acute interstitial nephritis of plasma cells: A new cause for renal allograft loss. Transplant Proc 1993; 25: 897-899.
5. Charney DA, Nadasdy T, Lo AW et al. Plasma cell-rich acute renal allograft rejection. Transplantation 1999; 68: 791-797.
6. Meehan SM, Domer P, Josephson M et al. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol 2001; 32: 205-215.
7. Suzuki T, Fukuzawa J, Furuya S et al. Renal graft loss with plasma cell-rich acute rejection in cadaveric renal transplantation: a case report. Clin Transplant 2005; 19: 71-75.
8. Sarwal M, Chua M, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125-138.
9. Lehnhardt A, Mengel M, Pape L, Ehrich JHH, Offner G, Strehlau J. Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab. Am J Transplantation 2006; 6: 847-851.
10. Aranda J Jr, Scornik JC, Lottenberg R et al. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection. Transplantation 2002; 73: 907-910.
11. Alausa M, Almagro U, Siddiqi N, Zuiderweg R, Medipalli R, Hariharan S. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab. Clin Transplant 2005; 19: 137-140.
12. Shapiro R, Basu A, Tan H, Gray E et al. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or campath. J Am Coll Surg 2005; 200: 505-515.
13. Hippen BE, DeMattos A, Cook WJ, Kew CE, Gaston RS. Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplantation 2005; 5: 2248-2252.
14. Kerjaschki D, Regele HM, Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J am soc nephrol 2004; 15: 603-612.
15. Baddoura FK, Nasr IW, Wrobel B, Li Q, Ruddle NH, Lakkis FG. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplantation 2005; 5: 510-516.
16. Ichikawa N, Demetris AJ, Starzl TE et al. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Liver Transpl 2000; 6: 686-702.
17. Guettier C, Nochy D, Hinglais N et al. Distinct phenotypic composition of diffuse interstitial and perivascular focal infiltrates in renal allografts: a morphometric analysis of cellular infiltration under conventional immunosuppressive therapy and under cyclosporine A. Clin nephrol 1988; 30: 97-105.
18. Nast CC, Moudgil A, Zuo XJ, Wilkinson A, Danovitch GM, Jordan SC. Cyclosporine microemulsion- and mycophenolate mofetil-related lymphoid aggregates are not associated with acute rejection. Transplantation. 2001; 72: 251-256.
19. Bishop GA, Hall BM, Duggin GG, Horvath JS, Sheil AG, Tiller DJ. Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers. Kidney Int 1986; 29: 708-717.
20. Grimm PC, McKenna R, Nickerson P et al. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol 1999; 10: 1582-1589.
21. Sako H, Nakane Y, Okino K et al. Immunohistochemical study of the cells infiltrating human renal allograft by the ABC and IGSS method using monoclonal antibodies. Transplantation 1987; 44: 43-50.
22. Hancock WW, Thomson NM, Atkins RC. Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 1983; 35: 458-463.
23. Kirk AD, Hale DA, Mannon RB et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody Alemtuzumab (Campath-1H). Transplantation 2003; 76: 120-129
24. McCurry K, Iacano A, Zeevi A et al. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg 2005; 130: 528-537.